Trials / Completed
CompletedNCT02147548
Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly
Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly. A Monocentric, Randomized, Cross-over, Double-blind Clinical Study Versus Placebo
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Biocodex · Industry
- Sex
- All
- Age
- 65 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effects of etifoxine (an anxiolytic) compared to lorazepam (a benzodiazepine anxiolytic) on vigilance and cognitive functions in the elderly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etifoxine | |
| DRUG | lorazepam | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2014-05-26
- Last updated
- 2016-07-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02147548. Inclusion in this directory is not an endorsement.